James Hartley. (2026). Aberrant Splicing Factor SF3A2 as a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay with Immune Infiltration and Natural Product Intervention. International Journal of Medical Science and Dental Health, 12(09), 176-181. https://doi.org/10.55640/ijmsdh-12-09-20